Concepedia
Statistics
Publications
29
Citations
3.4K
H-Index
22
Active since
1985
Affiliations
New Frontier(Current)
GlaxoSmithKline (United States)
GlaxoSmithKline (United Kingdom)
University Medical Center New Orleans
Timothy K. Hart is an author at New Frontier specializing in life sciences, pharmacology, and molecular biology.
Publications per year
1985–2019
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
Helai P. Mohammad, Kimberly N. Smitheman, Chandrashekhar D. Kamat et al. · Cancer Cell · 2015 · 512 citations · Full text
Medicine, Molecular Biology, Oncology +12
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 347 citations · Full text
Medicine, Oncology, Pharmacology +7
Physical, Morphological and Functional Differences between pH 5.8 and 7.4 Aggregates of the Alzheimer's Amyloid Peptide A β
Stephen Wood, Beverly E. Maleeff, Timothy K. Hart et al. · Journal of Molecular Biology · 1996 · 340 citations
Life Sciences, Biochemistry, Molecular Biology +16
In Vivo Myocardial Protection From Ischemia/Reperfusion Injury by the Peroxisome Proliferator–Activated Receptor-γ Agonist Rosiglitazone
Tianli Yue, Weike Bao, Padma Kumar Narayanan et al. · Circulation · 2001 · 296 citations · Full text
Medicine, Cardiology, Pharmacology +13
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
Jia Yi Fong, Luca Pignata, Pierre-Alexis Goy et al. · Cancer Cell · 2019 · 279 citations · Full text
Life Sciences, Molecular Biology, Pharmacology +16
1–5 of 29